Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
May 09, 2024
CGD NOTES
May 07, 2024
WORKING PAPERS
April 23, 2024
WORKING PAPERS
May 01, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CASE STUDIES
May 18, 2023
Antimicrobial resistance (AMR) poses a threat to global health security worldwide, and India carries one of the largest burdens of drug-resistant pathogens. The widespread misuse and overuse of antimicrobials is a major cause of the emergence and spread of resistant microorganisms. This study assess...
POLICY PAPERS
February 10, 2023
Bangladesh’s Primary Education Stipend Program provides stipends for 13 million primary schoolchildren to 10 million mothers. In 2017 the method of payment changed from cash to mobile money. This study considers the experience of the mothers with the shift to mobile money, and to the change in payme...
POLICY PAPERS
January 19, 2023
This study surveys Kenya's electronic payment system for social benefits, Inua Jamii, from the perspective of recipients, including their views on convenience and the benefits from competition. It also considers whether these digital G2P payments programs have increased financial inclusion more gene...
WORKING PAPERS
June 09, 2022
Does channeling government-to-person (G2P) payments through bank accounts encourage financial inclusion and use? This paper explores the factors that have driven the adoption of digital payments in India by beneficiaries of PMGKY, the large-scale COVID-19 relief program launched in May 2020.
BRIEFS
April 28, 2022
COVID-19 has disrupted health systems across the globe. Nigeria reported its first COVID-19 case in February 2020, and, since then, the government has rolled out four vaccines to help control the pandemic—Moderna, Oxford-Astra Zeneca (AZ), Johnson & Johnson (J&J) and Pfizer-BioNTech.